Using ARTIDIS to measure early breast lesions
Part of Cancer, Skin clinical trials.
This trial tests a new device called ARTIDIS that measures the stiffness of breast tissue to help identify early breast lesions. It may provide a noninvasive way to assess breast health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You can understand and sign a consent form.
- Your doctor has recommended a breast biopsy for diagnosis.
- You are able to perform daily activities with some help (ECOG score 0 to 3).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new, non-invasive scanning tool that uses harmless electrical signals to look at breast tissue. It may help doctors evaluate breast conditions without surgery, which could be useful for diagnosis or monitoring treatment.
This trial tests a device called OneMark that helps doctors find and track breast cancer during surgery and follow-up. It may help make sure the cancer is removed completely.
This study looks at proteins and imaging patterns (from tissue, fluid near the tumor, and blood) to better understand breast cancer markers. It may help researchers find clues that doctors can use to evaluate breast nodules and newly diagnosed invasive breast cancer.
This trial looks at how breast cancer works in the body, using new “mechanics” measurements to better guide treatment. It may be most helpful if you have (or may have) breast cancer and can take part in study visits and procedures.
This trial uses a special blood test to track cancer signals (called ctDNA) during and after treatment for early breast cancer. It aims to see whether monitoring these signals can help guide follow-up and treatment decisions.
This study tests a new, non-contact thermal camera (thermography) combined with artificial intelligence to find breast cancer. It is designed for women coming for routine screening, high-risk screening, or diagnostic exams, and aims to see if this painless, radiation-free method can help detect cancer earlier.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.